Skip to main content

Advertisement

SpringerLink
Log in

Liver fibrosis quantification

  • Special Section: Quantitative Imaging
  • Published:
Abdominal Radiology Aims and scope Submit manuscript

Abstract

Liver fibrosis (LF) is the wound healing response to chronic liver injury. LF is the endpoint of chronic liver disease (CLD) regardless of etiology and the single most important determinant of long-term liver-related clinical outcomes. Quantification of LF is important for staging, to evaluate response to treatment and to predict outcomes. LF is traditionally staged by liver biopsy. However, liver biopsy is invasive and suffers from sampling errors when biopsy size is inadequate; therefore, non-invasive tests (NITs) have found important roles in clinical care. NITs include simple laboratory-based serum tests, panels of serum tests, and imaging biomarkers. NITs are validated against the liver biopsy and will be used in the future for evaluation of nearly all CLDs with invasive liver biopsy reserved for some cases. Both serum tests and some imaging biomarkers such as elastography are currently used clinically as surrogate markers for LF. Several other imaging biomarkers are still considered research and awaiting clinical application in the future. As the evaluation of imaging biomarkers will likely become the norm in the future, understanding pathogenesis of LF is important. Knowledge of properties measured by imaging biomarkers and its correlation with LF is important to understand the application of NITs by abdominal radiologists. In this review, we present a brief overview of pathogenesis of LF, spatiotemporal evolution of LF in different CLD, and severity assessment with liver biopsy. This will be followed by a brief discussion on properties measured by imaging biomarkers and their relationship to the LF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

Data availability

No data available.

References

  1. Anthony PP, Ishak KG, Nayak NC, Poulsen HE, Scheuer PJ, Sobin LH (1977) The morphology of cirrhosis: definition, nomenclature, and classification. Bull World Health Organ 55 (4):521-540

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Hernandez-Gea V, Friedman SL (2011) Pathogenesis of liver fibrosis. Annu Rev Pathol 6:425-456. https://doi.org/10.1146/annurev-pathol-011110-130246

    Article  CAS  PubMed  Google Scholar 

  3. Rosenberg WM (2003) Rating fibrosis progression in chronic liver diseases. J Hepatol 38 (3):357-360. https://doi.org/10.1016/s0168-8278(03)00010-2

    Article  PubMed  Google Scholar 

  4. Angulo P, Kleiner DE, Dam-Larsen S, Adams LA, Bjornsson ES, Charatcharoenwitthaya P, Mills PR, Keach JC, Lafferty HD, Stahler A, Haflidadottir S, Bendtsen F (2015) Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology 149 (2):389-397.e310. https://doi.org/10.1053/j.gastro.2015.04.043

    Article  PubMed  Google Scholar 

  5. Horowitz JM, Venkatesh SK, Ehman RL, Jhaveri K, Kamath P, Ohliger MA, Samir AE, Silva AC, Taouli B, Torbenson MS, Wells ML, Yeh B, Miller FH (2017) Evaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel. Abdom Radiol (NY) 42 (8):2037-2053. https://doi.org/10.1007/s00261-017-1211-7

    Article  Google Scholar 

  6. Rockey DC, Bissell DM (2006) Noninvasive measures of liver fibrosis. Hepatology (Baltimore, Md) 43 (2 Suppl 1):S113-120. https://doi.org/10.1002/hep.21046

    Article  CAS  Google Scholar 

  7. Rockey DC (2008) Noninvasive assessment of liver fibrosis and portal hypertension with transient elastography. Gastroenterology 134 (1):8-14. https://doi.org/10.1053/j.gastro.2007.11.053

    Article  PubMed  Google Scholar 

  8. Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD, Diseases AAftSoL (2009) Liver biopsy. Hepatology (Baltimore, Md) 49 (3):1017-1044. https://doi.org/10.1002/hep.22742

    Article  Google Scholar 

  9. Petitclerc L, Gilbert G, Nguyen BN, Tang A (2017) Liver Fibrosis Quantification by Magnetic Resonance Imaging. Top Magn Reson Imaging 26 (6):229-241. https://doi.org/10.1097/rmr.0000000000000149

    Article  PubMed  PubMed Central  Google Scholar 

  10. Yin M, Venkatesh SK (2018) Ultrasound or MR elastography of liver: which one shall I use? Abdom Radiol (NY) 43 (7):1546-1551. https://doi.org/10.1007/s00261-017-1340-z

    Article  Google Scholar 

  11. Tang A, Cloutier G, Szeverenyi NM, Sirlin CB (2015) Ultrasound Elastography and MR Elastography for Assessing Liver Fibrosis: Part 2, Diagnostic Performance, Confounders, and Future Directions. AJR Am J Roentgenol 205 (1):33-40. https://doi.org/10.2214/AJR.15.14553

    Article  PubMed  PubMed Central  Google Scholar 

  12. Smith AD, Porter KK, Elkassem AA, Sanyal R, Lockhart ME (2019) Current Imaging Techniques for Noninvasive Staging of Hepatic Fibrosis. AJR Am J Roentgenol 213 (1):77-89. https://doi.org/10.2214/AJR.19.21144

    Article  PubMed  Google Scholar 

  13. Sun M, Kisseleva T (2015) Reversibility of liver fibrosis. Clin Res Hepatol Gastroenterol 39 Suppl 1:S60-63. https://doi.org/10.1016/j.clinre.2015.06.015

    Article  PubMed  PubMed Central  Google Scholar 

  14. Geerts A (2001) History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells. Semin Liver Dis 21 (3):311-335. https://doi.org/10.1055/s-2001-17550

    Article  CAS  PubMed  Google Scholar 

  15. Poynard T, Mathurin P, Lai CL, Guyader D, Poupon R, Tainturier MH, Myers RP, Muntenau M, Ratziu V, Manns M, Vogel A, Capron F, Chedid A, Bedossa P (2003) A comparison of fibrosis progression in chronic liver diseases. J Hepatol 38 (3):257-265

    Article  CAS  PubMed  Google Scholar 

  16. Bataller R, Brenner DA (2005) Liver fibrosis. J Clin Invest 115 (2):209-218. https://doi.org/10.1172/JCI24282

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Kisseleva T, Brenner DA (2008) Mechanisms of fibrogenesis. Exp Biol Med (Maywood) 233 (2):109-122. https://doi.org/10.3181/0707-MR-190

    Article  CAS  Google Scholar 

  18. Standish RA, Cholongitas E, Dhillon A, Burroughs AK, Dhillon AP (2006) An appraisal of the histopathological assessment of liver fibrosis. Gut 55 (4):569-578. https://doi.org/10.1136/gut.2005.084475

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Brenner DA, Waterboer T, Choi SK, Lindquist JN, Stefanovic B, Burchardt E, Yamauchi M, Gillan A, Rippe RA (2000) New aspects of hepatic fibrosis. J Hepatol 32 (1 Suppl):32-38. https://doi.org/10.1016/s0168-8278(00)80413-4

    Article  CAS  PubMed  Google Scholar 

  20. Issa R, Zhou X, Constandinou CM, Fallowfield J, Millward-Sadler H, Gaca MD, Sands E, Suliman I, Trim N, Knorr A, Arthur MJ, Benyon RC, Iredale JP (2004) Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking. Gastroenterology 126 (7):1795-1808. https://doi.org/10.1053/j.gastro.2004.03.009

    Article  CAS  PubMed  Google Scholar 

  21. Pellicoro A, Aucott RL, Ramachandran P, Robson AJ, Fallowfield JA, Snowdon VK, Hartland SN, Vernon M, Duffield JS, Benyon RC, Forbes SJ, Iredale JP (2012) Elastin accumulation is regulated at the level of degradation by macrophage metalloelastase (MMP-12) during experimental liver fibrosis. Hepatology (Baltimore, Md) 55 (6):1965-1975. https://doi.org/10.1002/hep.25567

    Article  CAS  Google Scholar 

  22. Pinzani M, Rombouts K (2004) Liver fibrosis: from the bench to clinical targets. Dig Liver Dis 36 (4):231-242. https://doi.org/10.1016/j.dld.2004.01.003

    Article  CAS  PubMed  Google Scholar 

  23. Safdar K, Schiff ER (2004) Alcohol and hepatitis C. Semin Liver Dis 24 (3):305-315. https://doi.org/10.1055/s-2004-832942

    Article  PubMed  Google Scholar 

  24. Shiffman ML, Stravitz RT, Contos MJ, Mills AS, Sterling RK, Luketic VA, Sanyal AJ, Cotterell A, Maluf D, Posner MP, Fisher RA (2004) Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation. Liver Transpl 10 (10):1248-1255. https://doi.org/10.1002/lt.20232

    Article  PubMed  Google Scholar 

  25. Benhamou Y, Bochet M, Di Martino V, Charlotte F, Azria F, Coutellier A, Vidaud M, Bricaire F, Opolon P, Katlama C, Poynard T (1999) Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology (Baltimore, Md) 30 (4):1054–1058. https://doi.org/10.1002/hep.510300409

  26. McGuire RF, Bissell DM, Boyles J, Roll FJ (1992) Role of extracellular matrix in regulating fenestrations of sinusoidal endothelial cells isolated from normal rat liver. Hepatology 15 (6):989-997. https://doi.org/10.1002/hep.1840150603

    Article  CAS  PubMed  Google Scholar 

  27. Hammoutene A, Rautou PE (2019) Role of liver sinusoidal endothelial cells in non-alcoholic fatty liver disease. J Hepatol 70 (6):1278-1291. https://doi.org/10.1016/j.jhep.2019.02.012

    Article  CAS  PubMed  Google Scholar 

  28. Lee JS, Semela D, Iredale J, Shah VH (2007) Sinusoidal remodeling and angiogenesis: a new function for the liver-specific pericyte? Hepatology 45 (3):817-825. https://doi.org/10.1002/hep.21564

    Article  CAS  PubMed  Google Scholar 

  29. Parola M, Pinzani M (2019) Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues. Mol Aspects Med 65:37-55. https://doi.org/10.1016/j.mam.2018.09.002

    Article  CAS  PubMed  Google Scholar 

  30. POPPER H, ELIAS H, PETTY DE (1952) Vascular pattern of the cirrhotic liver. Am J Clin Pathol 22 (8):717-729. https://doi.org/10.1093/ajcp/22.8.717

    Article  CAS  PubMed  Google Scholar 

  31. HALES MR, ALLAN JS, HALL EM (1959) Injection-corrosion studies of normal and cirrhotic livers. Am J Pathol 35:909-941

    CAS  PubMed  PubMed Central  Google Scholar 

  32. Kisseleva T, Brenner D (2021) Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol 18 (3):151-166. https://doi.org/10.1038/s41575-020-00372-7

    Article  PubMed  Google Scholar 

  33. Zois CD, Baltayiannis GH, Karayiannis P, Tsianos EV (2008) Systematic review: hepatic fibrosis - regression with therapy. Aliment Pharmacol Ther 28 (10):1175-1187. https://doi.org/10.1111/j.1365-2036.2008.03840.x

    Article  CAS  PubMed  Google Scholar 

  34. Serpaggi J, Carnot F, Nalpas B, Canioni D, Guechot J, Lebray P, Vallet-Pichard A, Fontaine H, Bedossa P, Pol S (2006) Direct and indirect evidence for the reversibility of cirrhosis. Hum Pathol 37 (12):1519-1526. https://doi.org/10.1016/j.humpath.2006.07.007

    Article  PubMed  Google Scholar 

  35. Abdalla AF, Zalata KR, Ismail AF, Shiha G, Attiya M, Abo-Alyazeed A (2009) Regression of fibrosis in paediatric autoimmune hepatitis: morphometric assessment of fibrosis versus semiquantiatative methods. Fibrogenesis Tissue Repair 2 (1):2. https://doi.org/10.1186/1755-1536-2-2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Ellis EL, Mann DA (2012) Clinical evidence for the regression of liver fibrosis. J Hepatol 56 (5):1171-1180. https://doi.org/10.1016/j.jhep.2011.09.024

    Article  PubMed  Google Scholar 

  37. Vukobrat-Bijedic Z, Husic-Selimovic A, Mehinovic L, Mehmedovic A, Junuzovic D, Bjelogrlic I, Sofic A, Djurovic A (2014) Analysis of effect of antiviral therapy on regression of liver fibrosis in patient with HCV infection. Mater Sociomed 26 (3):172-176. https://doi.org/10.5455/msm.2014.26.172-176

    Article  PubMed  PubMed Central  Google Scholar 

  38. Hammel P, Couvelard A, O'Toole D, Ratouis A, Sauvanet A, Fléjou JF, Degott C, Belghiti J, Bernades P, Valla D, Ruszniewski P, Lévy P (2001) Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct. N Engl J Med 344 (6):418-423. https://doi.org/10.1056/NEJM200102083440604

    Article  CAS  PubMed  Google Scholar 

  39. Arthur MJ (2002) Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C. Gastroenterology 122 (5):1525-1528. https://doi.org/10.1053/gast.2002.33367

    Article  PubMed  Google Scholar 

  40. Kweon YO, Goodman ZD, Dienstag JL, Schiff ER, Brown NA, Burchardt E, Schoonhoven R, Brenner DA, Fried MW, Burkhardt E (2001) Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B. J Hepatol 35 (6):749-755. https://doi.org/10.1016/s0168-8278(01)00218-5

    Article  CAS  PubMed  Google Scholar 

  41. Dixon JB, Bhathal PS, Hughes NR, O'Brien PE (2004) Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss. Hepatology (Baltimore, Md) 39 (6):1647-1654. https://doi.org/10.1002/hep.20251

    Article  Google Scholar 

  42. Czaja AJ, Carpenter HA (2004) Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis. J Hepatol 40 (4):646-652. https://doi.org/10.1016/j.jhep.2004.01.009

    Article  CAS  PubMed  Google Scholar 

  43. Parés A, Caballería J, Bruguera M, Torres M, Rodés J (1986) Histological course of alcoholic hepatitis. Influence of abstinence, sex and extent of hepatic damage. J Hepatol 2 (1):33–42. https://doi.org/10.1016/s0168-8278(86)80006-x

  44. Hafeez S, Ahmed MH (2013) Bariatric surgery as potential treatment for nonalcoholic fatty liver disease: a future treatment by choice or by chance? J Obes 2013:839275. https://doi.org/10.1155/2013/839275

    Article  PubMed  PubMed Central  Google Scholar 

  45. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J (1981) Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology (Baltimore, Md) 1 (5):431-435. https://doi.org/10.1002/hep.1840010511

    Article  CAS  Google Scholar 

  46. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RN (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22 (6):696-699. https://doi.org/10.1016/0168-8278(95)80226-6

    Article  CAS  PubMed  Google Scholar 

  47. Scheuer PJ (1991) Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 13 (3):372-374. https://doi.org/10.1016/0168-8278(91)90084-o

    Article  CAS  PubMed  Google Scholar 

  48. Batts KP, Ludwig J (1995) Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 19 (12):1409–1417. https://doi.org/10.1097/00000478-199512000-00007

  49. Bedossa P, Poynard T (1996) An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology (Baltimore, Md) 24 (2):289–293. https://doi.org/10.1002/hep.510240201

  50. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ, Network NSCR (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology (Baltimore, Md) 41 (6):1313-1321. https://doi.org/10.1002/hep.20701

    Article  Google Scholar 

  51. Dai DF, Swanson PE, Krieger EV, Liou IW, Carithers RL, Yeh MM (2014) Congestive hepatic fibrosis score: a novel histologic assessment of clinical severity. Mod Pathol 27 (12):1552-1558. https://doi.org/10.1038/modpathol.2014.79

    Article  PubMed  Google Scholar 

  52. Bedossa P, Dargere D, Paradis V (2003) Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology (Baltimore, Md) 38 (6):1449-1457. https://doi.org/10.1016/j.hep.2003.09.022

    Article  Google Scholar 

  53. Poynard T, Ratziu V, Bedossa P (2000) Appropriateness of liver biopsy. Canadian journal of gastroenterology = Journal canadien de gastroenterologie 14 (6):543–548

  54. Rousselet MC, Michalak S, Dupre F, Croue A, Bedossa P, Saint-Andre JP, Cales P (2005) Sources of variability in histological scoring of chronic viral hepatitis. Hepatology (Baltimore, Md) 41 (2):257-264. https://doi.org/10.1002/hep.20535

    Article  Google Scholar 

  55. Goodman ZD, Becker RL, Pockros PJ, Afdhal NH (2007) Progression of fibrosis in advanced chronic hepatitis C: evaluation by morphometric image analysis. Hepatology (Baltimore, Md) 45 (4):886-894. https://doi.org/10.1002/hep.21595

    Article  CAS  Google Scholar 

  56. Sun W, Chang S, Tai DC, Tan N, Xiao G, Tang H, Yu H (2008) Nonlinear optical microscopy: use of second harmonic generation and two-photon microscopy for automated quantitative liver fibrosis studies. J Biomed Opt 13 (6):064010. https://doi.org/10.1117/1.3041159

    Article  CAS  PubMed  Google Scholar 

  57. Tai DC, Tan N, Xu S, Kang CH, Chia SM, Cheng CL, Wee A, Wei CL, Raja AM, Xiao G, Chang S, Rajapakse JC, So PT, Tang HH, Chen CS, Yu H (2009) Fibro-C-Index: comprehensive, morphology-based quantification of liver fibrosis using second harmonic generation and two-photon microscopy. J Biomed Opt 14 (4):044013. https://doi.org/10.1117/1.3183811

    Article  CAS  PubMed  Google Scholar 

  58. Gawrieh S, Sethunath D, Cummings OW, Kleiner DE, Vuppalanchi R, Chalasani N, Tuceryan M (2020) Automated quantification and architectural pattern detection of hepatic fibrosis in NAFLD. Ann Diagn Pathol 47:151518. https://doi.org/10.1016/j.anndiagpath.2020.151518

    Article  PubMed  PubMed Central  Google Scholar 

  59. Yu Y, Wang J, Ng CW, Ma Y, Mo S, Fong ELS, Xing J, Song Z, Xie Y, Si K, Wee A, Welsch RE, So PTC, Yu H (2018) Deep learning enables automated scoring of liver fibrosis stages. Sci Rep 8 (1):16016. https://doi.org/10.1038/s41598-018-34300-2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Bedossa P (2010) Harmony in liver fibrosis.. J Hepatol 52 (3):313-314. https://doi.org/10.1016/j.jhep.2009.11.020

    Article  PubMed  Google Scholar 

  61. Friedman SL (2008) Hepatic fibrosis -- overview. Toxicology 254 (3):120-129. https://doi.org/10.1016/j.tox.2008.06.013

    Article  CAS  PubMed  Google Scholar 

  62. Garcia-Tsao G, Friedman S, Iredale J, Pinzani M (2010) Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis. Hepatology 51 (4):1445-1449. https://doi.org/10.1002/hep.23478

    Article  PubMed  Google Scholar 

  63. Nagula S, Jain D, Groszmann RJ, Garcia-Tsao G (2006) Histological-hemodynamic correlation in cirrhosis-a histological classification of the severity of cirrhosis. J Hepatol 44 (1):111-117. https://doi.org/10.1016/j.jhep.2005.07.036

    Article  PubMed  Google Scholar 

  64. Kumar M, Sakhuja P, Kumar A, Manglik N, Choudhury A, Hissar S, Rastogi A, Sarin SK (2008) Histological subclassification of cirrhosis based on histological-haemodynamic correlation. Aliment Pharmacol Ther 27 (9):771-779. https://doi.org/10.1111/j.1365-2036.2008.03653.x

    Article  CAS  PubMed  Google Scholar 

  65. Kim MY, Cho MY, Baik SK, Park HJ, Jeon HK, Im CK, Won CS, Kim JW, Kim HS, Kwon SO, Eom MS, Cha SH, Kim YJ, Chang SJ, Lee SS (2011) Histological subclassification of cirrhosis using the Laennec fibrosis scoring system correlates with clinical stage and grade of portal hypertension. J Hepatol 55 (5):1004-1009. https://doi.org/10.1016/j.jhep.2011.02.012

    Article  PubMed  Google Scholar 

  66. Sethasine S, Jain D, Groszmann RJ, Garcia-Tsao G (2012) Quantitative histological-hemodynamic correlations in cirrhosis. Hepatology (Baltimore, Md) 55 (4):1146-1153. https://doi.org/10.1002/hep.24805

    Article  Google Scholar 

  67. Khalifa A, Rockey DC (2020) The utility of liver biopsy in 2020. Curr Opin Gastroenterol 36 (3):184-191. https://doi.org/10.1097/MOG.0000000000000621

    Article  PubMed  Google Scholar 

  68. Bravo AA, Sheth SG, Chopra S (2001) Liver biopsy. N Engl J Med 344 (7):495-500. https://doi.org/10.1056/nejm200102153440706

    Article  CAS  PubMed  Google Scholar 

  69. Ratziu V, Charlotte F, Heurtier A, Gombert S, Giral P, Bruckert E, Grimaldi A, Capron F, Poynard T, Group LS (2005) Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 128 (7):1898-1906. https://doi.org/10.1053/j.gastro.2005.03.084

    Article  Google Scholar 

  70. Maharaj B, Maharaj RJ, Leary WP, Cooppan RM, Naran AD, Pirie D, Pudifin DJ (1986) Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet (London, England) 1 (8480):523-525

    Article  CAS  Google Scholar 

  71. Abdi W, Millan JC, Mezey E (1979) Sampling variability on percutaneous liver biopsy. Arch Intern Med 139 (6):667-669

    Article  CAS  PubMed  Google Scholar 

  72. Berzigotti A, Boursier J, Castera L, Cazzagon N, Friedrich-Rust M, Petta S, Thiele M, Tsochatzis E, Liver EAftSot, order) Lopma (2021) Easl Clinical Practice Guidelines (Cpgs) On Non-Invasive Tests For Evaluation Of Liver Disease Severity And Prognosis- 2020 Update. J Hepatol. https://doi.org/10.1016/j.jhep.2021.05.025

  73. Baranova A, Lal P, Birerdinc A, Younossi ZM (2011) Non-invasive markers for hepatic fibrosis. BMC Gastroenterol 11:91. https://doi.org/10.1186/1471-230X-11-91

    Article  PubMed  PubMed Central  Google Scholar 

  74. Pinzani M, Rombouts K, Colagrande S (2005) Fibrosis in chronic liver diseases: diagnosis and management. J Hepatol 42 Suppl (1):S22–36. https://doi.org/10.1016/j.jhep.2004.12.008

  75. Parikh P, Ryan JD, Tsochatzis EA (2017) Fibrosis assessment in patients with chronic hepatitis B virus (HBV) infection. Ann Transl Med 5 (3):40. https://doi.org/10.21037/atm.2017.01.28

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Lin ZH, Xin YN, Dong QJ, Wang Q, Jiang XJ, Zhan SH, Sun Y, Xuan SY (2011) Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology (Baltimore, Md) 53 (3):726-736. https://doi.org/10.1002/hep.24105

    Article  Google Scholar 

  77. Salkic NN, Jovanovic P, Hauser G, Brcic M (2014) FibroTest/Fibrosure for significant liver fibrosis and cirrhosis in chronic hepatitis B: a meta-analysis. Am J Gastroenterol 109 (6):796-809. https://doi.org/10.1038/ajg.2014.21

    Article  PubMed  Google Scholar 

  78. Poynard T, Morra R, Halfon P, Castera L, Ratziu V, Imbert-Bismut F, Naveau S, Thabut D, Lebrec D, Zoulim F, Bourliere M, Cacoub P, Messous D, Munteanu M, de Ledinghen V (2007) Meta-analyses of FibroTest diagnostic value in chronic liver disease. BMC Gastroenterol 7:40. https://doi.org/10.1186/1471-230X-7-40

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  79. Houot M, Ngo Y, Munteanu M, Marque S, Poynard T (2016) Systematic review with meta-analysis: direct comparisons of biomarkers for the diagnosis of fibrosis in chronic hepatitis C and B. Aliment Pharmacol Ther 43 (1):16-29. https://doi.org/10.1111/apt.13446

    Article  CAS  PubMed  Google Scholar 

  80. Xie Q, Zhou X, Huang P, Wei J, Wang W, Zheng S (2014) The performance of enhanced liver fibrosis (ELF) test for the staging of liver fibrosis: a meta-analysis. PLoS One 9 (4):e92772. https://doi.org/10.1371/journal.pone.0092772

    Article  PubMed  PubMed Central  Google Scholar 

  81. Xiao G, Zhu S, Xiao X, Yan L, Yang J, Wu G (2017) Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis. Hepatology (Baltimore, Md) 66 (5):1486-1501. https://doi.org/10.1002/hep.29302

    Article  CAS  Google Scholar 

  82. Xu XY, Wang WS, Zhang QM, Li JL, Sun JB, Qin TT, Liu HB (2019) Performance of common imaging techniques vs serum biomarkers in assessing fibrosis in patients with chronic hepatitis B: A systematic review and meta-analysis. World J Clin Cases 7 (15):2022-2037. https://doi.org/10.12998/wjcc.v7.i15.2022

    Article  PubMed  PubMed Central  Google Scholar 

  83. Dong B, Lyu G, Chen Y, Lin G, Wang H, Qin R, Gu J (2021) Comparison of two-dimensional shear wave elastography, magnetic resonance elastography, and three serum markers for diagnosing fibrosis in patients with chronic hepatitis B: a meta-analysis. Expert Rev Gastroenterol Hepatol 15 (9):1077-1089. https://doi.org/10.1080/17474124.2021.1880894

    Article  CAS  PubMed  Google Scholar 

  84. Lu Q, Lu C, Li J, Ling W, Qi X, He D, Liu J, Wen T, Wu H, Zhu H, Luo Y (2016) Stiffness Value and Serum Biomarkers in Liver Fibrosis Staging: Study in Large Surgical Specimens in Patients with Chronic Hepatitis B. Radiology 280 (1):290-299. https://doi.org/10.1148/radiol.2016151229

    Article  PubMed  Google Scholar 

  85. Shiha G, Ibrahim A, Helmy A, Sarin SK, Omata M, Kumar A, Bernstien D, Maruyama H, Saraswat V, Chawla Y, Hamid S, Abbas Z, Bedossa P, Sakhuja P, Elmahatab M, Lim SG, Lesmana L, Sollano J, Jia JD, Abbas B, Omar A, Sharma B, Payawal D, Abdallah A, Serwah A, Hamed A, Elsayed A, AbdelMaqsod A, Hassanein T, Ihab A, GHaziuan H, Zein N, Kumar M (2017) Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update. Hepatol Int 11 (1):1-30. https://doi.org/10.1007/s12072-016-9760-3

    Article  PubMed  Google Scholar 

  86. Singh S, Muir AJ, Dieterich DT, Falck-Ytter YT (2017) American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases. Gastroenterology 152 (6):1544-1577. https://doi.org/10.1053/j.gastro.2017.03.016

    Article  PubMed  Google Scholar 

  87. Lim JK, Flamm SL, Singh S, Falck-Ytter YT, Association CGCotAG (2017) American Gastroenterological Association Institute Guideline on the Role of Elastography in the Evaluation of Liver Fibrosis. Gastroenterology 152 (6):1536-1543. https://doi.org/10.1053/j.gastro.2017.03.017

    Article  PubMed  Google Scholar 

  88. Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM, Sanyal AJ (2018) The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology (Baltimore, Md) 67 (1):328-357. https://doi.org/10.1002/hep.29367

    Article  Google Scholar 

  89. Huber A, Ebner L, Heverhagen JT, Christe A (2015) State-of-the-art imaging of liver fibrosis and cirrhosis: A comprehensive review of current applications and future perspectives. European Journal of Radiology Open 2:90-100. https://doi.org/10.1016/j.ejro.2015.05.002

    Article  PubMed  PubMed Central  Google Scholar 

  90. Brown JJ, Naylor MJ, Yagan N (1997) Imaging of hepatic cirrhosis. Radiology 202 (1):1-16. https://doi.org/10.1148/radiology.202.1.8988182

    Article  CAS  PubMed  Google Scholar 

  91. Brancatelli G, Federle MP, Ambrosini R, Lagalla R, Carriero A, Midiri M, Vilgrain V (2007) Cirrhosis: CT and MR imaging evaluation. Eur J Radiol 61 (1):57-69. https://doi.org/10.1016/j.ejrad.2006.11.003

    Article  PubMed  Google Scholar 

  92. Dodd GD, Baron RL, Oliver JH, Federle MP (1999) Spectrum of imaging findings of the liver in end-stage cirrhosis: part I, gross morphology and diffuse abnormalities. AJR Am J Roentgenol 173 (4):1031-1036. https://doi.org/10.2214/ajr.173.4.10511173

    Article  PubMed  Google Scholar 

  93. Zhang YN, Fowler KJ, Boehringer AS, Montes V, Schlein AN, Covarrubias Y, Wolfson T, Hong CW, Valasek MA, Andre MP, Loomba R, Sirlin CB (2021) Comparative diagnostic performance of ultrasound shear wave elastography and magnetic resonance elastography for classifying fibrosis stage in adults with biopsy-proven nonalcoholic fatty liver disease. Eur Radiol. https://doi.org/10.1007/s00330-021-08369-9

    Article  PubMed  PubMed Central  Google Scholar 

  94. Hsu C, Caussy C, Imajo K, Chen J, Singh S, Kaulback K, Le MD, Hooker J, Tu X, Bettencourt R, Yin M, Sirlin CB, Ehman RL, Nakajima A, Loomba R (2019) Magnetic Resonance vs Transient Elastography Analysis of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Pooled Analysis of Individual Participants. Clin Gastroenterol Hepatol 17 (4):630-637.e638. https://doi.org/10.1016/j.cgh.2018.05.059

    Article  PubMed  Google Scholar 

  95. Selvaraj EA, Mózes FE, Jayaswal ANA, Zafarmand MH, Vali Y, Lee JA, Levick CK, Young LAJ, Palaniyappan N, Liu CH, Aithal GP, Romero-Gómez M, Brosnan MJ, Tuthill TA, Anstee QM, Neubauer S, Harrison SA, Bossuyt PM, Pavlides M, Investigators L (2021) Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis. J Hepatol 75 (4):770-785. https://doi.org/10.1016/j.jhep.2021.04.044

    Article  PubMed  Google Scholar 

  96. Sharpton SR, Tamaki N, Bettencourt R, Madamba E, Jung J, Liu A, Behling C, Valasek MA, Loomba R (2021) Diagnostic accuracy of two-dimensional shear wave elastography and transient elastography in nonalcoholic fatty liver disease. Therap Adv Gastroenterol 14:17562848211050436. https://doi.org/10.1177/17562848211050436

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  97. Singh S, Venkatesh SK, Wang Z, Miller FH, Motosugi U, Low RN, Hassanein T, Asbach P, Godfrey EM, Yin M, Chen J, Keaveny AP, Bridges M, Bohte A, Murad MH, Lomas DJ, Talwalkar JA, Ehman RL (2015) Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data. Clin Gastroenterol Hepatol 13 (3):440-451.e446. https://doi.org/10.1016/j.cgh.2014.09.046

    Article  PubMed  Google Scholar 

  98. Singh S, Venkatesh SK, Loomba R, Wang Z, Sirlin C, Chen J, Yin M, Miller FH, Low RN, Hassanein T, Godfrey EM, Asbach P, Murad MH, Lomas DJ, Talwalkar JA, Ehman RL (2016) Magnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease: a diagnostic accuracy systematic review and individual participant data pooled analysis. Eur Radiol 26 (5):1431-1440. https://doi.org/10.1007/s00330-015-3949-z

    Article  PubMed  Google Scholar 

  99. Wang QB, Zhu H, Liu HL, Zhang B (2012) Performance of magnetic resonance elastography and diffusion-weighted imaging for the staging of hepatic fibrosis: A meta-analysis. Hepatology (Baltimore, Md) 56 (1):239-247. https://doi.org/10.1002/hep.25610

    Article  Google Scholar 

  100. Bota S, Herkner H, Sporea I, Salzl P, Sirli R, Neghina AM, Peck-Radosavljevic M (2013) Meta-analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis. Liver International 33 (8):1138-1147. https://doi.org/10.1111/liv.12240

    Article  PubMed  Google Scholar 

  101. Hu X, Qiu L, Liu D, Qian L (2017) Acoustic Radiation Force Impulse (ARFI) Elastography for non‑invasive evaluation of hepatic fibrosis in chronic hepatitis B and C patients: a systematic review and meta-analysis. Med Ultrason 19 (1):23-31. https://doi.org/10.11152/mu-942

    Article  PubMed  Google Scholar 

  102. Imajo K, Honda Y, Kobayashi T, Nagai K, Ozaki A, Iwaki M, Kessoku T, Ogawa Y, Takahashi H, Saigusa Y, Yoneda M, Kirikoshi H, Utsunomiya D, Aishima S, Saito S, Nakajima A (2020) Direct Comparison of US and MR Elastography for Staging Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. https://doi.org/10.1016/j.cgh.2020.12.016

    Article  PubMed  Google Scholar 

  103. Takayama Y, Nishie A, Asayama Y, Ushijima Y, Okamoto D, Fujita N, Morita K, Shirabe K, Kotoh K, Kubo Y, Okuaki T, Honda H (2015) T1 ρ Relaxation of the liver: A potential biomarker of liver function. J Magn Reson Imaging 42 (1):188-195. https://doi.org/10.1002/jmri.24739

    Article  PubMed  Google Scholar 

  104. Banerjee R, Pavlides M, Tunnicliffe EM, Piechnik SK, Sarania N, Philips R, Collier JD, Booth JC, Schneider JE, Wang LM, Delaney DW, Fleming KA, Robson MD, Barnes E, Neubauer S (2014) Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease. J Hepatol 60 (1):69-77. https://doi.org/10.1016/j.jhep.2013.09.002

    Article  PubMed  PubMed Central  Google Scholar 

  105. Hoffman DH, Ayoola A, Nickel D, Han F, Chandarana H, Shanbhogue KP (2020) T1 mapping, T2 mapping and MR elastography of the liver for detection and staging of liver fibrosis. Abdom Radiol (NY) 45 (3):692-700. https://doi.org/10.1007/s00261-019-02382-9

    Article  Google Scholar 

  106. Smith AD, Branch CR, Zand K, Subramony C, Zhang H, Thaggard K, Hosch R, Bryan J, Vasanji A, Griswold M, Zhang X (2016) Liver Surface Nodularity Quantification from Routine CT Images as a Biomarker for Detection and Evaluation of Cirrhosis. Radiology 280 (3):771-781. https://doi.org/10.1148/radiol.2016151542

    Article  PubMed  Google Scholar 

  107. Lubner MG, Jones D, Said A, Kloke J, Lee S, Pickhardt PJ (2018) Accuracy of liver surface nodularity quantification on MDCT for staging hepatic fibrosis in patients with hepatitis C virus. Abdom Radiol (NY). https://doi.org/10.1007/s00261-018-1572-6

    Article  Google Scholar 

  108. Pickhardt PJ, Malecki K, Kloke J, Lubner MG (2016) Accuracy of Liver Surface Nodularity Quantification on MDCT as a Noninvasive Biomarker for Staging Hepatic Fibrosis. AJR Am J Roentgenol 207 (6):1194-1199. https://doi.org/10.2214/AJR.16.16514

    Article  PubMed  Google Scholar 

  109. Kim SW, Kim YR, Choi KH, Cho EY, Song JS, Kim JE, Kim TH, Lee YH, Yoon KH (2020) Staging of Liver Fibrosis by Means of Semiautomatic Measurement of Liver Surface Nodularity in MRI. AJR Am J Roentgenol 215 (3):624-630. https://doi.org/10.2214/AJR.19.22041

    Article  PubMed  Google Scholar 

  110. Catania R, Furlan A, Smith AD, Behari J, Tublin ME, Borhani AA (2021) Diagnostic value of MRI-derived liver surface nodularity score for the non-invasive quantification of hepatic fibrosis in non-alcoholic fatty liver disease. Eur Radiol 31 (1):256-263. https://doi.org/10.1007/s00330-020-07114-y

    Article  CAS  PubMed  Google Scholar 

  111. Dioguardi Burgio M, Sartoris R, Beaufrere A, Grégory J, Guiu B, Guillot C, Rautou PE, Castera L, Bouattour M, Paradis V, Vilgrain V, Ronot M (2021) Liver surface nodularity on non-contrast MRI identifies advanced fibrosis in patients with NAFLD. Eur Radiol. https://doi.org/10.1007/s00330-021-08261-6

    Article  PubMed  Google Scholar 

  112. Barr RG, Wilson SR, Rubens D, Garcia-Tsao G, Ferraioli G (2020) Update to the Society of Radiologists in Ultrasound Liver Elastography Consensus Statement. Radiology 296 (2):263-274. https://doi.org/10.1148/radiol.2020192437

    Article  PubMed  Google Scholar 

  113. Schawkat K, Ciritsis A, von Ulmenstein S, Honcharova-Biletska H, Jüngst C, Weber A, Gubler C, Mertens J, Reiner CS (2020) Diagnostic accuracy of texture analysis and machine learning for quantification of liver fibrosis in MRI: correlation with MR elastography and histopathology. Eur Radiol 30 (8):4675-4685. https://doi.org/10.1007/s00330-020-06831-8

    Article  PubMed  Google Scholar 

  114. Lubner MG, Jones D, Kloke J, Said A, Pickhardt PJ (2019) CT texture analysis of the liver for assessing hepatic fibrosis in patients with hepatitis C virus. Br J Radiol 92 (1093):20180153. https://doi.org/10.1259/bjr.20180153

    Article  PubMed  Google Scholar 

  115. Choi KJ, Jang JK, Lee SS, Sung YS, Shim WH, Kim HS, Yun J, Choi JY, Lee Y, Kang BK, Kim JH, Kim SY, Yu ES (2018) Development and Validation of a Deep Learning System for Staging Liver Fibrosis by Using Contrast Agent-enhanced CT Images in the Liver. Radiology 289 (3):688-697. https://doi.org/10.1148/radiol.2018180763

    Article  PubMed  Google Scholar 

  116. Yasaka K, Akai H, Kunimatsu A, Abe O, Kiryu S (2018) Deep learning for staging liver fibrosis on CT: a pilot study. Eur Radiol 28 (11):4578-4585. https://doi.org/10.1007/s00330-018-5499-7

    Article  PubMed  Google Scholar 

  117. Yasaka K, Akai H, Kunimatsu A, Abe O, Kiryu S (2018) Liver Fibrosis: Deep Convolutional Neural Network for Staging by Using Gadoxetic Acid-enhanced Hepatobiliary Phase MR Images. Radiology 287 (1):146-155. https://doi.org/10.1148/radiol.2017171928

    Article  PubMed  Google Scholar 

  118. Hectors SJ, Kennedy P, Huang KH, Stocker D, Carbonell G, Greenspan H, Friedman S, Taouli B (2021) Fully automated prediction of liver fibrosis using deep learning analysis of gadoxetic acid-enhanced MRI. Eur Radiol 31 (6):3805-3814. https://doi.org/10.1007/s00330-020-07475-4

    Article  CAS  PubMed  Google Scholar 

  119. Phelps A (2019) Liver Ultrasound Texture Analysis: The Computer Finds More to Quantify Than Meets the Eye. Acad Radiol 26 (8):1008-1009. https://doi.org/10.1016/j.acra.2019.03.013

    Article  PubMed  Google Scholar 

  120. Lazzarini AL, Levine RA, Ploutz-Snyder RJ, Sanderson SO (2005) Advances in digital quantification technique enhance discrimination between mild and advanced liver fibrosis in chronic hepatitis C. Liver Int 25 (6):1142-1149. https://doi.org/10.1111/j.1478-3231.2005.01155.x

    Article  PubMed  Google Scholar 

  121. Masugi Y, Abe T, Tsujikawa H, Effendi K, Hashiguchi A, Abe M, Imai Y, Hino K, Hige S, Kawanaka M, Yamada G, Kage M, Korenaga M, Hiasa Y, Mizokami M, Sakamoto M (2018) Quantitative assessment of liver fibrosis reveals a nonlinear association with fibrosis stage in nonalcoholic fatty liver disease. Hepatol Commun 2 (1):58-68. https://doi.org/10.1002/hep4.1121

    Article  CAS  PubMed  Google Scholar 

  122. Poynard T, Lenaour G, Vaillant JC, Capron F, Munteanu M, Eyraud D, Ngo Y, M'Kada H, Ratziu V, Hannoun L, Charlotte F (2012) Liver biopsy analysis has a low level of performance for diagnosis of intermediate stages of fibrosis. Clin Gastroenterol Hepatol 10 (6):657-663.e657. https://doi.org/10.1016/j.cgh.2012.01.023

    Article  PubMed  Google Scholar 

  123. Mehta SH, Lau B, Afdhal NH, Thomas DL (2009) Exceeding the limits of liver histology markers. J Hepatol 50 (1):36-41. https://doi.org/10.1016/j.jhep.2008.07.039

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Dr. Venkatesh acknowledges support from National Institute of Health Grant (EB001981) and U.S. Department of Defense Grant (W81XWH-19-1-0583-01).

Funding

The authors did not receive support from any organization for the submitted work.

Author information

Authors and Affiliations

  1. Abdominal Imaging Division, Department of Radiology, Mayo Clinic, 200, First Street SW, Rochester, MN, 55905, USA

    Sudhakar K. Venkatesh

  2. Anatomic Pathology Division, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA

    Michael S. Torbenson

Authors
  1. Sudhakar K. Venkatesh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael S. Torbenson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sudhakar K. Venkatesh.

Ethics declarations

Conflict of interest

Financial interests: The author declares no financial interests. Non-financial interests: The author declares no non-financial interests.

Research involving human participants and/or animals

This review article did not involve any research involving human participants and/or animals. No ethics approval was needed.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Venkatesh, S.K., Torbenson, M.S. Liver fibrosis quantification. Abdom Radiol 47, 1032–1052 (2022). https://doi.org/10.1007/s00261-021-03396-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-021-03396-y

Keywords

Search

Navigation